Although reduction in primary tumor growth did not require CD8 T cell involvement (Figure 6B), depletion of CD8 T cells largely reversed the ACA + rapamycin-mediated reductions in lung metastases and led to a rebound in lung metastatic burden (Figure 6C). This evidence concerns the gene CD8A and neoplasm.